Addressing prescription drug cost transparency.

By resolution, returned to House Rules Committee for third reading.

Placed on second reading by Rules Committee.

Passed to Rules Committee for second reading.

Minority; without recommendation.

Minority; do not pass.

Minority; without recommendation.

First reading, referred to Health & Long Term Care.

Third reading, passed; yeas, 50; nays, 48; absent, 0; excused, 0.

Rules Committee relieved of further consideration. Placed on third reading.

By resolution, returned to House Rules Committee for third reading.

First reading, referred to Health Care.

Third reading, passed; yeas, 52; nays, 46; absent, 0; excused, 0.

Rules suspended. Placed on Third Reading.

2nd substitute bill substituted.

Rules Committee relieved of further consideration. Placed on second reading.

Minority; do not pass.

Minority; without recommendation.

Minority; do not pass.

First reading, referred to Health Care & Wellness (Not Officially read and referred until adoption of Introduction report).